Does the media prefer DVA or LFST?

In the previous week, DaVita had 3 more articles in the media than LifeStance Health Group. MarketBeat recorded 10 mentions for DaVita and 7 mentions for LifeStance Health Group. DaVita's average media sentiment score of 1.79 beat LifeStance Health Group's score of 0.71 indicating that DaVita is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DaVita 10 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive LifeStance Health Group 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LFST or TEM?

In the previous week, Tempus AI had 45 more articles in the media than LifeStance Health Group. MarketBeat recorded 52 mentions for Tempus AI and 7 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.71 beat Tempus AI's score of 0.57 indicating that LifeStance Health Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Tempus AI 27 Very Positive mention(s) 4 Positive mention(s) 10 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LFST or HNGE?

In the previous week, Hinge Health had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 13 mentions for Hinge Health and 7 mentions for LifeStance Health Group. Hinge Health's average media sentiment score of 0.96 beat LifeStance Health Group's score of 0.71 indicating that Hinge Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeStance Health Group 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Hinge Health 8 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

LifeStance Health Group (LFST) Competitors

$12.16 -0.31 (-2.49%)

Closing price 04:00 PM Eastern

Extended Trading

$12.36 +0.21 (+1.69%)

As of 04:52 PM Eastern

Compare

LFST vs. FMS, BTSG, DVA, TEM, and HNGE

Should you buy LifeStance Health Group stock or one of its competitors? LifeStance Health Group's main competitors and comparable companies include Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), DaVita (DVA), Tempus AI (TEM), and Hinge Health (HNGE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to LifeStance Health Group's net margin of 3.19%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
LifeStance Health Group	3.19%	3.39%	2.33%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than LifeStance Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.57	$1.11B	$1.93	12.18
LifeStance Health Group	$1.42B	3.31	$9.66M	$0.13	93.54

Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.14, meaning that its stock price is 14% more volatile than the broader market.

In the previous week, LifeStance Health Group had 5 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 7 mentions for LifeStance Health Group and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.27 beat LifeStance Health Group's score of 0.71 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $23.57, indicating a potential upside of 0.26%. LifeStance Health Group has a consensus price target of $12.38, indicating a potential upside of 1.77%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, analysts clearly believe LifeStance Health Group is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

Summary

LifeStance Health Group beats Fresenius Medical Care AG & Co. KGaA on 10 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

BrightSpring Health Services has higher revenue and earnings than LifeStance Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BrightSpring Health Services	$14.37B	0.82	$190.67M	$1.66	35.84
LifeStance Health Group	$1.42B	3.31	$9.66M	$0.13	93.54

LifeStance Health Group has a net margin of 3.19% compared to BrightSpring Health Services' net margin of 2.55%. BrightSpring Health Services' return on equity of 16.73% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BrightSpring Health Services	2.55%	16.73%	5.24%
LifeStance Health Group	3.19%	3.39%	2.33%

85.5% of LifeStance Health Group shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

BrightSpring Health Services presently has a consensus price target of $70.71, suggesting a potential upside of 18.85%. LifeStance Health Group has a consensus price target of $12.38, suggesting a potential upside of 1.77%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, equities analysts clearly believe BrightSpring Health Services is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

BrightSpring Health Services has a beta of 1.88, meaning that its share price is 88% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.14, meaning that its share price is 14% more volatile than the broader market.

In the previous week, BrightSpring Health Services had 1 more articles in the media than LifeStance Health Group. MarketBeat recorded 8 mentions for BrightSpring Health Services and 7 mentions for LifeStance Health Group. BrightSpring Health Services' average media sentiment score of 1.07 beat LifeStance Health Group's score of 0.71 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BrightSpring Health Services	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
LifeStance Health Group	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

BrightSpring Health Services beats LifeStance Health Group on 12 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to DaVita?

DaVita (NYSE:DVA) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

90.1% of DaVita shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 1.9% of DaVita shares are held by insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

DaVita has a beta of 0.88, indicating that its stock price is 12% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market.

DaVita has a net margin of 6.05% compared to LifeStance Health Group's net margin of 3.19%. LifeStance Health Group's return on equity of 3.39% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DaVita	6.05%	-217.63%	5.07%
LifeStance Health Group	3.19%	3.39%	2.33%

DaVita has higher revenue and earnings than LifeStance Health Group. DaVita is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DaVita	$14.01B	0.80	$746.80M	$12.22	14.45
LifeStance Health Group	$1.42B	3.31	$9.66M	$0.13	93.54

DaVita currently has a consensus target price of $221.75, suggesting a potential upside of 25.61%. LifeStance Health Group has a consensus target price of $12.38, suggesting a potential upside of 1.77%. Given DaVita's higher possible upside, equities analysts plainly believe DaVita is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DaVita	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

In the previous week, DaVita had 3 more articles in the media than LifeStance Health Group. MarketBeat recorded 10 mentions for DaVita and 7 mentions for LifeStance Health Group. DaVita's average media sentiment score of 1.79 beat LifeStance Health Group's score of 0.71 indicating that DaVita is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DaVita	10 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
LifeStance Health Group	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DaVita beats LifeStance Health Group on 9 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Tempus AI?

LifeStance Health Group (NASDAQ:LFST) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership.

LifeStance Health Group has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.31	$9.66M	$0.13	93.54
Tempus AI	$1.27B	9.39	-$245.03M	-$1.44	N/A

In the previous week, Tempus AI had 45 more articles in the media than LifeStance Health Group. MarketBeat recorded 52 mentions for Tempus AI and 7 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.71 beat Tempus AI's score of 0.57 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Tempus AI	27 Very Positive mention(s)	4 Positive mention(s)	10 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeStance Health Group currently has a consensus price target of $12.38, suggesting a potential upside of 1.77%. Tempus AI has a consensus price target of $65.69, suggesting a potential downside of 0.72%. Given LifeStance Health Group's stronger consensus rating and higher probable upside, equities research analysts plainly believe LifeStance Health Group is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Tempus AI	2 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.41

LifeStance Health Group has a net margin of 3.19% compared to Tempus AI's net margin of -17.77%. LifeStance Health Group's return on equity of 3.39% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Tempus AI	-17.77%	-50.28%	-10.33%

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

LifeStance Health Group has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.58, suggesting that its stock price is 258% more volatile than the broader market.

Summary

LifeStance Health Group beats Tempus AI on 12 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Hinge Health?

LifeStance Health Group (NASDAQ:LFST) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

LifeStance Health Group presently has a consensus target price of $12.38, indicating a potential upside of 1.77%. Hinge Health has a consensus target price of $100.57, indicating a potential upside of 12.01%. Given Hinge Health's stronger consensus rating and higher probable upside, analysts clearly believe Hinge Health is more favorable than LifeStance Health Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeStance Health Group	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
Hinge Health	1 Sell rating(s)	2 Hold rating(s)	14 Buy rating(s)	1 Strong Buy rating(s)	2.83

Hinge Health has a net margin of 15.15% compared to LifeStance Health Group's net margin of 3.19%. Hinge Health's return on equity of 51.60% beat LifeStance Health Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeStance Health Group	3.19%	3.39%	2.33%
Hinge Health	15.15%	51.60%	14.16%

LifeStance Health Group has higher revenue and earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeStance Health Group	$1.42B	3.31	$9.66M	$0.13	93.54
Hinge Health	$720.06M	10.06	-$528.26M	$1.28	70.14

In the previous week, Hinge Health had 6 more articles in the media than LifeStance Health Group. MarketBeat recorded 13 mentions for Hinge Health and 7 mentions for LifeStance Health Group. Hinge Health's average media sentiment score of 0.96 beat LifeStance Health Group's score of 0.71 indicating that Hinge Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeStance Health Group	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
Hinge Health	8 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LifeStance Health Group has a beta of 1.14, suggesting that its stock price is 14% more volatile than the broader market. Comparatively, Hinge Health has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market.

85.5% of LifeStance Health Group shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by insiders. Comparatively, 18.9% of Hinge Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Hinge Health beats LifeStance Health Group on 12 of the 16 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LFST vs. The Competition

Export

Metric	LifeStance Health Group	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$4.72B	$9.92B	$7.29B	$12.71B
Dividend Yield	N/A	2.55%	2.54%	10.79%
P/E Ratio	93.55	34.42	271.38	24.10
Price / Sales	3.31	4.82	638.95	90.12
Price / Cash	74.13	24.64	29.03	36.90
Price / Book	3.11	5.37	11.18	6.40
Net Income	$9.66M	$309.96M	$3.46B	$348.28M
7 Day Performance	-3.11%	0.13%	1.98%	0.91%
1 Month Performance	11.56%	1.43%	7.32%	5.10%
1 Year Performance	119.10%	15.25%	24.76%	16.16%

LifeStance Health Group Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LFST LifeStance Health Group	3.1824 of 5 stars	$12.16 -2.5%	$12.38 +1.8%	+124.7%	$4.72B	$1.42B	93.55	10,961
FMS Fresenius Medical Care AG & Co. KGaA	3.1475 of 5 stars	$23.59 +0.4%	$23.57 -0.1%	-8.4%	$12.67B	$22.20B	12.22	1,488	Positive News
BTSG BrightSpring Health Services	4.9645 of 5 stars	$59.49 -1.5%	$70.71 +18.9%	+136.7%	$11.77B	$14.37B	35.84	23,500	Positive News Analyst Downgrade
DVA DaVita	4.8943 of 5 stars	$178.09 +0.8%	$221.75 +24.5%	+24.2%	$11.36B	$14.01B	14.57	78,000	Positive News
TEM Tempus AI	1.5652 of 5 stars	$49.36 -4.4%	$64.92 +31.5%	-9.7%	$8.91B	$1.27B	N/A	3,800	Trending News Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LFST) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

LifeStance Health Group (LFST) Competitors

LFST vs. FMS, BTSG, DVA, TEM, and HNGE

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does LifeStance Health Group compare to BrightSpring Health Services?

Summary

How does LifeStance Health Group compare to DaVita?

Summary

How does LifeStance Health Group compare to Tempus AI?

Summary

How does LifeStance Health Group compare to Hinge Health?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

LifeStance Health Group (LFST) Competitors

LFST vs. FMS, BTSG, DVA, TEM, and HNGE

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Is FMS or LFST more profitable?

Which has better valuation and earnings, FMS or LFST?

Which has more risk & volatility, FMS or LFST?

Does the media prefer FMS or LFST?

Do institutionals and insiders believe in FMS or LFST?

Do analysts rate FMS or LFST?

Summary

How does LifeStance Health Group compare to BrightSpring Health Services?

Which has higher valuation and earnings, BTSG or LFST?

Is BTSG or LFST more profitable?

Do institutionals & insiders have more ownership in BTSG or LFST?

Do analysts rate BTSG or LFST?

Which has more risk and volatility, BTSG or LFST?

Does the media prefer BTSG or LFST?

Summary

How does LifeStance Health Group compare to DaVita?

Do insiders & institutionals hold more shares of DVA or LFST?

Which has more volatility & risk, DVA or LFST?

Is DVA or LFST more profitable?

Which has higher valuation and earnings, DVA or LFST?

Do analysts prefer DVA or LFST?

Does the media prefer DVA or LFST?

Summary

How does LifeStance Health Group compare to Tempus AI?

Which has better valuation & earnings, LFST or TEM?

Does the media favor LFST or TEM?

Do analysts rate LFST or TEM?

Is LFST or TEM more profitable?

Do insiders and institutionals have more ownership in LFST or TEM?

Which has more risk and volatility, LFST or TEM?

Summary

How does LifeStance Health Group compare to Hinge Health?

Do analysts rate LFST or HNGE?

Is LFST or HNGE more profitable?

Which has preferable earnings & valuation, LFST or HNGE?

Does the media favor LFST or HNGE?

Which has more risk & volatility, LFST or HNGE?

Do insiders & institutionals believe in LFST or HNGE?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LFST vs. The Competition

LifeStance Health Group Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools